-
Isradipine (Dynacirc): Reliable Assay Workflows
2026-08-31
This scenario-driven guide explains how Isradipine (Dynacirc), SKU A8453, can support interpretable calcium-channel experiments involving viability, proliferation, cytotoxicity, vascular, and neuronal models. It combines mechanism-aware assay design with practical preparation, storage, comparison, and data-quality guidance.
-
(R)-MG132: A Rigorous Proteasome Control
2026-08-31
(R)-MG132 is a functionally inactive MG-132 enantiomer designed to separate proteasome-dependent effects from solvent, stress, and off-target responses. This guide presents paired biochemical and cellular workflows, practical dosing parameters, and troubleshooting strategies for stronger ubiquitin-proteasome system research.
-
Camptothecin A2877: Reliable DNA Damage Assays
2026-08-30
Learn how Camptothecin (SKU A2877) can improve interpretation of viability, proliferation, DNA-damage, and autophagy assays. This scenario-based guide covers mechanism, solubility, protocol optimization, cross-domain interpretation, and practical vendor selection for reproducible laboratory workflows.
-
Resiniferatoxin (RTX) Workflows for TRPV1 Research
2026-08-29
Resiniferatoxin (RTX) converts a brief TRPV1 calcium signal into durable sensory-neuron desensitization, making it useful for pain, neurogenic inflammation, and target-validation studies. This practical guide connects calcium-imaging assays with intra-articular, perineural, and intrathecal research workflows while emphasizing controls, tissue targeting, and troubleshooting.
-
Gepotidacin: Reliable Antibacterial Assays
2026-08-29
A scenario-driven guide to using Gepotidacin (GSK2140944; SKU BA1220) in bacterial viability, proliferation, and mechanism-focused assays. It covers concentration design, DMSO compatibility, MIC interpretation, orthogonal validation, and practical product-selection criteria.
-
Monomethyl auristatin E (MMAE) Workflow Guide
2026-08-28
Learn how to deploy Monomethyl auristatin E as a controlled antimitotic assay reagent and antibody-drug conjugate payload. The workflow separates intrinsic cytotoxicity from target-mediated delivery and connects MMAE response profiling with tumor-cell plasticity research.
-
Solanesol (B8776): Handling and QC Guide
2026-08-28
Solanesol (B8776) is a hydrophobic polyisoprenoid alcohol for membrane-related biochemical workflows, including apoptosis research, DNA damage and repair studies, and enzyme assays. It should be prepared in DMSO rather than water or ethanol, with fresh working solutions and controlled vehicle exposure used to reduce precipitation and assay-interference risk.
-
GPX3, JNK/c-Jun, and Gemcitabine Sensitivity
2026-08-27
This study identifies GPX3 as a potential tumor-suppressive regulator in pancreatic cancer, linking its loss to malignant behavior and reduced gemcitabine sensitivity. Using gain-of-function, phenotypic, molecular, and rescue experiments, the authors place JNK/c-Jun signaling downstream of GPX3 and provide a mechanistic framework for studying chemotherapy resistance.
-
Mycobacterium tuberculosis WecA: Kinetics and Purification
2026-08-27
A 2026 study establishes a practical expression, purification, and activity-testing workflow for the difficult membrane enzyme WecA from Mycobacterium tuberculosis. By combining tunable expression in Escherichia coli with affinity purification, mass-spectrometric identification, UMP-based kinetic analysis, and validation of tunicamycin as a competitive inhibitor, the work strengthens WecA as a biochemical and anti-tuberculosis drug-discovery target.
-
Dabigatran Etexilate: Oral Direct Thrombin Inhibition
2026-08-26
The reference review examines dabigatran etexilate as the first oral direct thrombin inhibitor marketed in the United States, emphasizing its rapid onset, predictable anticoagulant effects, and reduced dependence on routine coagulation monitoring. Its findings support a differentiated approach to stroke prevention in nonvalvular atrial fibrillation and venous thromboembolism, while also underscoring bleeding risk and the need for renal-function-based dosing.
-
(S)-(+)-Methoprene Assay Workflows
2026-08-26
Use (S)-(+)-Methoprene as a stereochemically defined juvenile hormone analog to connect Methoprene-tolerant signaling with developmental, reproductive, and receptor-level phenotypes. This practical guide covers dosing, miRNA–mRNA study design, controls, troubleshooting, and interpretation across arthropod assays.
-
SCH772984 HCl: Selective ERK1/2 Inhibition
2026-08-25
SCH772984 HCl is a selective ERK1/2 inhibitor for mechanistic studies of MAPK signaling, BRAF-mutant cancer research, and resistance biology. Vendor-reported biochemical potency, tumor-cell activity, and xenograft regression support its use as a research tool, while the relationship between ERK inhibition and APEX2-dependent TERT expression remains an untested hypothesis.
-
PEI-Laminarin Nanoparticles Boost Vaccine Responses
2026-08-25
This study developed polyethyleneimine-modified Laminarin nanoparticles as a cationic adjuvant platform for ovalbumin delivery. The formulation improved dendritic-cell uptake, maturation, lysosomal escape, antigen cross-presentation, and downstream humoral and cellular immune responses compared with an aluminum adjuvant.
-
PA-824: From Nitro Reduction to TB Regimen Design
2026-08-24
A translational perspective on how PA-824 links nitro-reduction, cell-wall disruption, terminal oxidase inhibition, and rational combination design in tuberculosis research.
-
SIRT1–PGC-1α–TFAM Protects N2a Mitochondria
2026-08-23
Zhao et al. show that SIRT1 protects prion peptide-treated N2a cells by restoring PGC-1α–TFAM-dependent mitochondrial biogenesis, thereby improving mitochondrial integrity and reducing apoptosis. The study positions Resveratrol as a useful pharmacological probe for testing this pathway, while also identifying important limitations for translating an in vitro mechanism into prion-disease research.
450 records 6/30 page Previous Next First page 上5页 678910 下5页 Last page